Document Detail

Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients.
MedLine Citation:
PMID:  19965537     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND OBJECTIVES: Removal of beta2-microglobulin (beta2M) can be increased by adding convective transport to hemodialysis (HD). The aim of this study was to investigate the change in beta2M levels after 6-mo treatment with hemodiafiltration (HDF) and to evaluate the role of residual kidney function (RKF) and the amount of convective volume with this change.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Predialysis serum beta2M levels were evaluated in 230 patients with and 176 patients without RKF from the CONvective TRAnsport STudy (CONTRAST) at baseline and 6 mo after randomization for online HDF or low-flux HD. In HDF patients, potential determinants of change in beta2M were analyzed using multivariable linear regression models.
RESULTS: Mean serum beta2M levels decreased from 29.5 +/- 0.8 (+/-SEM) at baseline to 24.3 +/- 0.6 mg/L after 6 mo in HDF patients and increased from 31.9 +/- 0.9 to 34.4 +/- 1.0 mg/L in HD patients, with the difference of change between treatment groups being statistically significant (regression coefficient -7.7 mg/L, 95% confidence interval -9.5 to -5.6, P < 0.001). This difference was more pronounced in patients without RKF as compared with patients with RKF. In HDF patients, beta2M levels remained unchanged in patients with GFR >4.2 ml/min/1.73 m2. The beta2M decrease was not related to convective volume.
CONCLUSIONS: This study demonstrated effective lowering of beta2M levels by HDF, especially in patients without RKF. The role of the amount of convective volume on beta2M decrease appears limited, possibly because of resistance to beta2M transfer between body compartments.
E Lars Penne; Neelke C van der Weerd; Peter J Blankestijn; Marinus A van den Dorpel; Muriel P C Grooteman; Menso J Nubé; Piet M Ter Wee; Renée Lévesque; Michiel L Bots;
Related Documents :
21264807 - Do thyroid cancer patients with basal undetectable tg measured by current immunoassays ...
9422437 - Right atrial silicone catheters as angioaccess for hemodialysis with special emphasis t...
11675417 - Survival and development of cardiovascular disease by modality of treatment in patients...
17786277 - Inflammatory status in patients with chronic renal failure: the role of ptx3 and pro-in...
23233577 - Hemostatic defects in liver and renal dysfunction.
3899247 - Ultrasonographic detection of early and curable carcinoma of the gallbladder.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2009-11-12
Journal Detail:
Title:  Clinical journal of the American Society of Nephrology : CJASN     Volume:  5     ISSN:  1555-905X     ISO Abbreviation:  Clin J Am Soc Nephrol     Publication Date:  2010 Jan 
Date Detail:
Created Date:  2010-01-21     Completed Date:  2010-05-25     Revised Date:  2011-07-19    
Medline Journal Info:
Nlm Unique ID:  101271570     Medline TA:  Clin J Am Soc Nephrol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  80-6     Citation Subset:  IM    
Department of Nephrology, VU Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Hemodiafiltration* / methods
Kidney / physiopathology*
Middle Aged
beta 2-Microglobulin / blood*
Reg. No./Substance:
0/beta 2-Microglobulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Renal replacement therapy in infants with chronic renal failure in the first year of life.
Next Document:  Long-term outcome of infants with severe chronic kidney disease.